Pyruvate Kinase Deficiency Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AGIO | C | Agios Pharmaceuticals, Inc. | 0.41 | |
RCKT | D | Rocket Pharmaceuticals, Inc. | -1.14 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Pyruvate Kinase Deficiency stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GNOM | D | Global X Genomics & Biotechnology ETF | 3.58 | |
HRTS | C | Tema Cardiovascular and Metabolic ETF | 2.78 | |
MEDI | C | Harbor Health Care ETF | 2.65 | |
BBP | D | BioShares Biotechnology Products Fund | 2.5 | |
HELX | A | Franklin Genomic Advancements ETF | 2.0 |
Compare ETFs
Related Industries:
Biotechnology
- Pyruvate Kinase Deficiency
Pyruvate kinase deficiency is an inherited metabolic disorder of the enzyme pyruvate kinase which affects the survival of red blood cells. Both autosomal dominant and recessive inheritance have been observed with the disorder; classically, and more commonly, the inheritance is autosomal recessive. Pyruvate kinase deficiency is the second most common cause of enzyme-deficient hemolytic anemia, following G6PD deficiency.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles